Today, Israel Chemicals Ltd. (ICL) Posts Quarterly Earnings Results, Meets Expectations

Today, Israel Chemicals Ltd. (ICL) Posts Quarterly  Earnings Results, Meets Expectations

Israel Chemicals Ltd. (NYSE:ICL) issued its quarterly earnings results on Wednesday. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. The company earned $1.38 billion during the quarter. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. The company’s quarterly revenue was up .3% on a year-over-year basis. During the same period in the previous year, the company posted $0.12 EPS.

Israel Chemicals (NYSE:ICL) traded down 1.84% during midday trading on Friday, reaching $3.73. The company had a trading volume of 8,080 shares. Israel Chemicals has a one year low of $3.52 and a one year high of $5.23. The stock has a market capitalization of $4.75 billion, a price-to-earnings ratio of 11.77 and a beta of 1.14. The company has a 50-day moving average price of $3.74 and a 200-day moving average price of $3.99.

A number of large investors have recently bought and sold shares of ICL. Public Sector Pension Investment Board raised its stake in Israel Chemicals by 19.0% in the second quarter. Public Sector Pension Investment Board now owns 96,656 shares of the company’s stock valued at $374,000 after buying an additional 15,400 shares in the last quarter. Alliancebernstein L.P. raised its stake in shares of Israel Chemicals by 1.6% in the second quarter. Alliancebernstein L.P. now owns 496,495 shares of the company’s stock valued at $1,936,000 after buying an additional 7,874 shares during the period. Canada Pension Plan Investment Board raised its stake in shares of Israel Chemicals by 20.2% in the second quarter. Canada Pension Plan Investment Board now owns 1,788,370 shares of the company’s stock valued at $6,929,000 after buying an additional 300,800 shares during the period. Commonwealth Bank of Australia raised its stake in shares of Israel Chemicals by 17.1% in the second quarter. Commonwealth Bank of Australia now owns 322,971 shares of the company’s stock valued at $1,251,000 after buying an additional 47,189 shares during the period. Finally, Vanguard Group Inc. raised its stake in shares of Israel Chemicals by 1.5% in the second quarter. Vanguard Group Inc. now owns 8,841,883 shares of the company’s stock valued at $34,484,000 after buying an additional 131,595 shares during the period. 6.51% of the stock is owned by institutional investors.

Separately, Zacks Investment Research raised Israel Chemicals from a “hold” rating to a “buy” rating and set a $4.25 price target for the company in a research note on Monday.

Related posts

Leave a Comment